Jobs Available at the Brain Health Institute

Greg Brown Endowed Chair and Director of Rutgers Addiction Research Center
We seek a well-funded, accomplished scientist, at senior Associate Professor or Professor level, to join the Rutgers Biomedical and Health Sciences (RBHS) Department of Psychiatry and Rutgers Brain Health Institute. With broad expertise in addictive and substance use disorders, the appointee will serve as the inaugural Director of a new Rutgers University Addiction Research Center (RUARC). The RUARC will build collaborations among scientists with the multidisciplinary expertise required to advance our understanding of the causes of opioid addiction and other substance use disorders. As a component of the Brain Health Institute, RUARC will contain faculty in all Rutgers schools and campuses with expertise in addiction prevention, research, treatment, education, and public policy. Participating elements include especially Robert Wood Johnson Medical School (RWJMS), New Jersey Medical School (NJMS), School of Arts and Sciences, Center for Alcohol Studies, Center for Tobacco Studies, School of Public Health, School of Social Work, School of Nursing, School of Health Professions (SHP), University Behavioral Health Care, School of Pharmacy, the Institute for Health, Health Care Policy and Aging Research, and the affiliated U.S. Dept. of Veterans Affairs Medical Centers in East Orange and Lyons, NJ. RUARC will be the only comprehensive addiction center in NJ with the capacity to address the addiction epidemic through the diverse strengths of its members by integrating the following cutting edge approaches:

  • Precision Medicine preclinical research and knowledge development that crosses multiple disciplines and addresses individual differences and needs in addiction treatment.
  • Treatment and care of individuals and families coping with addiction.
  • Public policy innovation and reform aimed at preventing development of drug use and at more effective avenues for addicts to obtain treatment.
  • Inter-professional education of tomorrow's research, clinical, and criminal justice workforces from multiple disciplines in all aspects of addiction science.

The ideal candidate will be a clinician-scientist who is a leader in addiction research with a strong, externally-funded research program and who utilizes basic or clinical approaches to address key questions regarding addiction.  Candidates with expertise in opioid addiction, or who can apply their experience in other substance use disorders to opioid addiction, as well as those incorporating functional brain imaging to study addiction, will be of particular interest. With two teaching hospitals and over 250 neuroscience faculty labs in Newark and New Brunswick/Piscataway, as well as proximity to the New York, Princeton and Philadelphia neuroscience communities, Rutgers offers tremendous collaborative opportunities and core facilities to support and grow an outstanding research program.  The candidate for the Greg Brown Chair should also be a leader who can coordinate research among many faculty, form the nexus of a collaborative research focus or center, and develop new research opportunities.  Applicants must have a PhD, MD or equivalent doctoral degree, with demonstrated ability to lead an independent NIH-funded research program in addiction research. We offer substantial resources to develop a world-class addiction research center, and to support the director’s own research activities.  Rutgers UBHC has partnerships with the New Jersey Department of Corrections and Department of Mental Health and Addiction Services with access to large EHR databases. Rutgers NJMS operates the Northern NJ Center of Excellence in Medication-Assisted Treatment.  With a newly awarded NIH CTSA, Rutgers also offers unique opportunities to speed the translation of research discoveries into improved patient care. Outstanding core facilities will support this position, including a new research-dedicated 3T MRI scanner and a human behavioral testing core developed in collaboration with Princeton University. In addition, Rutgers has the world’s largest university-based biorepository, RUCDR, to facilitate genetic studies. Rutgers values a culturally diverse faculty; we strongly encourage applications from female and minority candidates. Applicants should submit a CV and statement of research accomplishments and plans to Dr. Frank Ghinassi, the Chair of the search committee, at bhi@ca.rutgers.edu.

Rutgers, The State University of New Jersey, is an Equal Opportunity/Affirmative Action Employer. Qualified applicants will be considered for employment without regard to race, creed, color, religion, sex, sexual orientation, gender identity or expression, national origin, disability status, genetic information, protected veteran status, military service or any other category protected by law.  As an institution, we value diversity of background and opinion, and prohibit discrimination or harassment on the basis of any legally protected class in the areas of hiring, recruitment, promotion, transfer, demotion, training, compensation, pay fringe benefits, layoff, termination or any other terms and conditions of employment. 

Krieger Klein Endowed Chair and Director of the Krieger Klein Alzheimer's Disease and Cognitive Neurology Clinical Research Center
The Honorable Herbert C. and Jacqueline Krieger Klein have funded a new Endowed Chair in Neurodegeneration Research as part of the Rutgers University Brain Health Institute.  We seek a well-funded, accomplished clinician-scientist, at senior Associate Professor or Professor level, working in the field of Alzheimer’s disease and cognitive neurology. We are particularly interested in someone with experience in leading clinical trials to develop new therapeutics in this area. As a member of the Rutgers Biomedical and Health Sciences (RBHS) Department of Neurology, the faculty appointee will be expected to establish a clinical practice focused on Alzheimer’s disease and cognitive neurology. This faculty member would also lead as Director of the Krieger Klein Alzheimer's Disease and Cognitive Neurology Clinical Research Center within the Rutgers Brain Health Institute. The Center will grow existing strengths in Alzheimer's disease, cognitive neurology and related neurodegenerative disorders at Rutgers and facilitate translational and clinical research in Alzheimer’s disease and cognitive neurology.  The ideal candidate will be a clinical research leader with a track record of a funded research program as it relates to Alzheimer’s disease and cognitive Neurology, who would dovetail with existing strengths at Rutgers in Alzheimer’s, Parkinson’s, cognitive neurology, multiple sclerosis, traumatic brain injury, epilepsy, spinal cord injury and other related research.  Applicants must have an MD or MD/PhD degree, with demonstrated ability to apply for an independent NIH-funded clinical and translational research program. In addition to the $3 million Endowed Chair, we offer a competitive salary and substantial resources to develop a world-class Alzheimer's Disease and Cognitive Neurology Clinical Research Center and to support the Director’s own clinical research activities.  The clinical research activities will be facilitated by the newly formed Rutgers Health, an innovative, statewide academic health care provider organization across New Jersey that brings together all Rutgers clinical activities under one umbrella.  The Rutgers University Behavioral Health Care (UBHC) with its unit, Comprehensive Services on Aging (COPSA), include a multidisciplinary team of geriatric psychiatrists, social workers, trainers and peer support specialists who provide expert care and support for individuals and their families dealing with memory loss.  The COPSA Institute for Alzheimer's Disease and Related Disorders is a statewide program that includes the Memory Disorders Clinic, Care2Caregivers Helpline, Training and Consultation Department.  With a newly awarded NIH CTSA, Rutgers offers unique opportunities to speed the translation of research discoveries into improved patient care. With two teaching hospitals and over 250 neuroscience faculty labs in Newark, New Brunswick and Piscataway, as well as proximity to the New York, Princeton and Philadelphia neuroscience communities, Rutgers offers tremendous collaborative opportunities and core facilities to support an active translational and clinical research program. Outstanding core facilities will support this position, including a new research-dedicated 3T MRI scanner and a human behavioral testing core in collaboration with Princeton University. In addition, Rutgers has the world’s largest university-based biorepository, RUCDR, which will facilitate genetic studies. Rutgers values a culturally diverse faculty; we strongly encourage applications from women and underrepresented in medicine candidates. Applicants should submit a CV and statement of research accomplishments and plans and names of three to five references to Dr. Suhayl Dhib-Jalbut, MD, the Chair of the search committee, at bhi@ca.rutgers.edu.

Rutgers, The State University of New Jersey, is an Equal Opportunity/Affirmative Action Employer. Qualified applicants will be considered for employment without regard to race, creed, color, religion, sex, sexual orientation, gender identity or expression, national origin, disability status, genetic information, protected veteran status, military service or any other category protected by law.  As an institution, we value diversity of background and opinion, and prohibit discrimination or harassment on the basis of any legally protected class in the areas of hiring, recruitment, promotion, transfer, demotion, training, compensation, pay fringe benefits, layoff, termination or any other terms and conditions of employment.

Post Doctoral Positions in Neuroscience at the Rutgers Brain Health Institute

Dr. Vanessa Routh's lab has a grant-funded post-doctoral position available immediately to investigate mechanisms of central glucose sensing and regulation of glucose homeostasis. Very strong preference given to electrophysiologists with expertise in patch clamp recordings of neurons in brain slices. Stereotaxic surgical skills and behavioral experience with rodents desired. Please contact Dr. Vanessa Routh, Professor, Department of Pharmacology, Physiology and Neuroscience, Rutgers New Jersey Medical School. Email: routhvh@njms.rutgers.edu; Office phone: 973-972-1489.

Dr. Stella Elkabes lab has a position to investigate molecular mechanisms underlying neuropathic pain in mouse models of multiple sclerosis.  The lab uses AAV-mediated genetic manipulation in spinal cord and behavioral assays to identify molecular mechanisms of pain.  Apply to:  elkabest@njms.rutgers.edu

Dr. Zhiping Pang’s lab has two positions to study molecular mechanisms of synaptic regulation by peptidergic hormones using rodent model systems and human iPSCs. The lab is also funded by an NIH BRAIN initiative grant to develop novel technologies to study brain structure and function.  Apply to:  pangzh@rwjms.rutgers.edu

Dr. Pingyue Pan’s lab has a position to understand how synaptic Parkinson's disease risk variants, such as SYNJ1 and SNCA, dysregulate synaptic function. Experience in primary neuron culture, quantitative live imaging and mouse models required.  Apply to:  pingyue.pan@rutgers.edu .

Dr. Huaye Zhang’s lab has a position to study molecular mechanisms of hippocampal synaptic plasticity and neurodegeneration and the roles of cell polarity regulators. Experiences with mouse models, primary neuron cultures, confocal and/or two-photon imaging are highly preferable.  Apply to:  huaye.zhang@rutgers.edu .

Dr. Pierre-Olivier Polack’s lab has a position to investigate mechanisms adapting visual processing to the behavioral needs using two-photon calcium imaging in mice performing behavioral tasks. Knowledge of mechanisms underpinning visual processing and proficiency with Matlab required.  Apply to:  polack.po@rutgers.edu .

Dr. Yuan-Xiang Tao’s lab has a position to study molecular and cellular mechanisms underlying chronic pain and opioid-associated disorders.  Apply to: yt211@njms.rutgers.edu  .

Dr. Vincent B. McGinty’s lab has a position to study the neural basis of decision-making and other motivated behaviors, using behavioral techniques, single unit and population neurophysiology, machine learning, and computational modeling. Details at mcgintylab.org.  Apply to : vince.mcginty@rutgers.edu

Dr. M. Maral Mouradian’s lab has positions to study the molecular pathogenesis of Parkinson's disease with the goal to identify therapeutic targets and compounds. Experiments utilize in vitro, cellular and animal models examining behavioral, biochemical and molecular markers.  Apply to:  lk496@rwjms.rutgers.edu 

Dr. Radek Dobrowolski’s lab has two positions to study Alzheimer disease-associated mutants using a multitude of CRISPR/Cas9 edited human iPSCs and Drosophila models. The projects use novel optogenetic tools and live-cell imaging to model and study AD pathology.  Apply to:  r.dobrowolski@rutgers.edu

Dr. Isaac Edery’s lab has a position to study sleep-wake states, energy balance and thermal adaptation using the Drosophila model system to discover novel pathways interconnecting brain function with metabolic demands.  Apply to: edery@cabm.rutgers.edu .

Dr. Steven Levison’s lab has a position to study a specific subset of platelet-derived growth factor dependent neural progenitors during development, determine which types of brain cells they produce and to compare their transcriptional profiles to those of neural stem cells.  Apply to:  levisosw@njms.rutgers.edu .

The MNADRT Program at Rutgers invites applications for a NIAAA-funded T32 postdoctoral fellowship focusing on the genetic and environmental influences on the nervous system controlling stress dysregulation and pathogenesis in alcoholism and drug abuse.  Contact Dr. Dipak Sarkar for more information at: Dipak.sarkar@rutgers.edu